Pseudotumor cerebri in an infant after L-thyroxine therapy for transient neonatal hypothyroidism.
Pseudotumor cerebri is generally a benign disorder. It has been reported to occur in hypothyroidism, particularly after the initiation of L-thyroxine replacement therapy. Previous case reports have involved children primarily in the peripubertal age range (approximately 8 to 13 years). We report here the development of pseudotumor cerebri in an infant who required treatment with L-thyroxine for transient neonatal hypothyroidism as a result of maternal thyroid-stimulating hormone receptor-blocking antibodies.
Raghavan
S
S
Department of Pediatrics, Monteflore Medical Center, Albert Einstein College of Medicine, Bronx, New York 10467, USA.
DiMartino-Nardi
J
J
Saenger
P
P
Linder
B
B
D003409:Congenital Hypothyroidism; D005260:Female; D006801:Humans; D007037:Hypothyroidism / Q000188:drug therapy*; D007231:Infant, Newborn; D011559:Pseudotumor Cerebri / Q000139:chemically induced*; D013974:Thyroxine / Q000009:adverse effects* / Q000627:therapeutic use
D013974:Thyroxine